InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for the month of April 2023. The filing was submitted on April 26, 2023, and references a press release dated April 25, 2023. The filing indicates that InterCure reports annually on Form 20-F.
Financial Metrics
The provided filing text is limited to the Form 6-K cover page and does not include clear values for revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics.
Material Changes Versus Prior Period
The provided text does not describe material changes versus a prior comparable period. Exhibit 99.1, the referenced April 25, 2023 press release, is listed but its contents are not included.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook commentary, risk disclosures, contingencies, or information on unusual items.
Facts for Investor Verification
- Obtain and review Exhibit 99.1, the April 25, 2023 press release.
- Verify whether the press release contains financial results, operating updates, guidance, or material event disclosures.
- Confirm the relevant reporting period and any financial metrics in the underlying exhibit or related Form 20-F filings.
- Note that the filing was signed by Amos Cohen, Chief Financial Officer, on April 26, 2023.